Your browser does not support JavaScript!
林幸榮教授 Lin, Shing-Jong

教授 / 陽明臨床醫學研究所

image  
[ CV ]
  • Email: sjlin@vghtpe.gov.tw; sjlin@ym.edu.tw
  • Tel: (02) 28757434
  •  

    EDUCATION AND POSITIONS HELD:

    • Taipei Medical University, Taipei, Taiwan, (Medicine), 1972-1979, M.D.
    • Columbia University, New York, U.S.A., (Physiology), 1986-1989, Ph.D.
    • Chief, Division of Cardiology, Taipei Veterans General Hospital, 2004-2009
    • Director, Department of Medical Research and Education, Taipei Veterans General Hospital, 2009-
    • Associate Professor of Medicine, Institute of Clinical Medicine, National Yang-Ming University School of Medicine, Taipei, 1989-1993
    • Professor, Department of Microbiology and Immunology, Natl. Yang-Ming Univ., Taipei, Taiwan ,2001-present
    • Professor of Medicine, Institute of Clinical Medicine, National Yang-Ming University School of Medicine, Taipei, 1993-
    • Director, Institute of Clinical Medicine, National Yang-Ming University School of Medicine, Taipei, 1998-2004
    • Director, Cardiovascular Research Center, National Yang-Ming University, Taipei, 2005-
    • Associate Dean, School of Medicine, National Yang-Ming University, Taipei, 2009/08-

    HONORS:

    • Nong Ting Award, 1991, the Republic of China Society of Cardiology
    • Uchida International Award, 1993, Japan Foundation of Cardiovascular Research
    • Allan B. Dove Memorial Medal Award, 2005, the Wire Association International
    • Fellow, American College of Cardiology, 1992-
    • Fellow, European Society of Cardiology, 1990-

    RESEARCH INTERESTS:

    Dr. Shing-Jong Lin’s major researches are in the fields of 1. molecular pathogenesis of atherosclerosis; 2. the genetic studies of hypertension, dyslipidemia, and coronary artery disease; 3. the role of oxidative stress and inflammation in cardiovascular diseases; 4. the innovation in stent technology; 5. biomarkers and outcome in heart failure studies; 6. vascular medicine and the roles of endothelial progenitor cells in cardiovascular diseases. In vascular medicine studies, our group has demonstrated that high glucose may impair early and late EPCs by modifying nitric oxide-related but not oxidative stress-mediated mechanisms. The MMP-9 is essential for EPCs mobilization and homing in ischemia-induced angiogenesis. The statins, red wine intake, adiponectin, and far infrared may increase the number and function of EPCs.

    瀏覽數  
    將此文章推薦給親友
    請輸入此驗證碼
    Voice Play
    更換驗證碼